Hub : Traits :

Alcohol usually taken with meals

77 significantly associated models · 28 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	43073464	44618031	4	1	6.7e-09	8.9e-08	1.4e-01	92	HYI
2	1	150415631	151793174	2	1	5.6e-08	1.1e-06	7.4e-01	100	BNIPL
3	1	173103273	175663031	9	1	1.6e-10	1.2e-10	3.3e-02	89	ZBTB37
4	1	235988566	237463399	4	1	1.2e-09	3.5e-10	8.9e-02	93	RP11-385F5.4
5	3	70757099	71880670	1	1	3.0e-07	2.4e-09	2.5e-05	50	FOXP1
6	4	41746460	42336312	1	1	2.4e-07	1.2e-08	1.2e-02	81	SLC30A9
7	7	116660803	118207833	1	2	4.5e-08	1.3e-07	7.6e-01	100	CTTNBP2
8	11	56666189	58284951	3	2	2.3e-08	1.1e-07	1.0e+00	100	CTNND1 ZDHHC5
9	17	1588930	3000009	2	1	1.1e-09	8.1e-09	7.6e-02	91	RP1-59D14.1
10	18	34614002	35378540	1	1	9.0e-08	6.8e-07	1.1e-01	90	CELF4

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	1.62	1	0	0.0	0.00	1.0e+00	HYI
Depressed Affect (Nagel 2018)	4.93	6	1	2.2	-0.74	5.8e-02	CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Depression (Nagel 2018)	4.28	1	1	2.2	0.00	1.0e+00	ZDHHC5
Intelligence (Savage-Jansen 2018)	3.16	4	1	2.2	0.99	1.5e-02	FOXP1 HYI ZBTB37 ZDHHC5
Neuroticism (Nagel 2018)	6.84	6	3	6.7	-0.68	9.6e-02	CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Schizophrenia (2018)	2.64	3	0	0.0	0.00	1.0e+00	FOXP1 HYI ZDHHC5
Schizophrenia vs Biploar Disorder	3.79	2	0	0.0	0.00	1.0e+00	ZBTB37 ZDHHC5
Worry (Nagel 2018)	3.40	3	0	0.0	0.00	1.0e+00	SLC30A9 ZBTB37 ZDHHC5
Major Depression (MDD)	6.29	3	0	0.0	-0.57	4.3e-01	CTTNBP2 SLC30A9 ZDHHC5
Verbal and Numeric Reasoning (VNR)	2.88	3	1	2.2	0.00	1.0e+00	FOXP1 HYI ZDHHC5
Neuroticism (2016)	4.14	2	0	0.0	0.00	1.0e+00	CELF4 RP1-59D14.1
Schizophrenia (2014)	2.33	3	0	0.0	0.00	1.0e+00	FOXP1 HYI ZDHHC5
Blood Eosinophil Count	0.71	2	0	0.0	0.00	1.0e+00	CTNND1 ZDHHC5
Blood Platelet Count	1.66	3	3	6.7	0.00	1.0e+00	RP11-385F5.4 RP1-59D14.1 ZDHHC5
Blood Red Count	0.94	4	1	2.2	-0.10	9.0e-01	HYI RP1-59D14.1 ZBTB37 ZDHHC5
Blood White Count	0.82	2	0	0.0	0.00	1.0e+00	FOXP1 HYI
Heel T-Score	0.80	2	1	2.2	0.00	1.0e+00	RP1-59D14.1 ZDHHC5
BMI	1.58	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Height	0.59	5	1	2.2	0.60	2.9e-01	CELF4 CTTNBP2 HYI SLC30A9 ZDHHC5
Systolic Blood Pressure	2.63	3	2	4.4	0.00	1.0e+00	CTNND1 HYI ZDHHC5
Smoking Status	5.44	3	1	2.2	-0.95	5.1e-02	CTTNBP2 FOXP1 ZBTB37
Allergy or Eczema	1.31	1	0	0.0	0.00	1.0e+00	SLC30A9
Cardiovascular Disease	1.24	2	0	0.0	0.00	1.0e+00	BNIPL HYI
Respiratory disease	1.98	1	0	0.0	0.00	1.0e+00	ZBTB37
Type 2 Diabetes (T2D) (2018)	1.85	1	0	0.0	0.00	1.0e+00	CTTNBP2
Lung FEV1/FVC ratio	1.53	2	1	2.2	0.00	1.0e+00	CTTNBP2 ZDHHC5
Lung FVC	2.04	2	1	2.2	0.00	1.0e+00	CTTNBP2 FOXP1
Neuroticism	7.17	7	2	4.4	-0.73	4.1e-02	CELF4 CTNND1 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Chronotype (morning person)	1.89	2	0	0.0	0.00	1.0e+00	CTNND1 ZDHHC5
Hand grip strength (left)	1.48	2	0	0.0	0.00	1.0e+00	FOXP1 ZDHHC5
Number of treatments/medications taken	2.34	2	0	0.0	0.00	1.0e+00	FOXP1 ZBTB37
Sensitivity / hurt feelings	3.82	2	0	0.0	0.00	1.0e+00	CELF4 ZDHHC5
Frequency of depressed mood in last 2 weeks	4.71	2	0	0.0	0.00	1.0e+00	SLC30A9 ZDHHC5
Relative age of first facial hair	2.54	3	0	0.0	0.00	1.0e+00	BNIPL HYI ZBTB37
Systolic blood pressure, automated reading	2.39	3	0	0.0	0.00	1.0e+00	HYI RP11-385F5.4 ZDHHC5
Vitamin and mineral supplements	2.36	1	0	0.0	0.00	1.0e+00	SLC30A9
Supplements: Zinc	2.71	1	0	0.0	0.00	1.0e+00	SLC30A9
Medication: Metformin	2.02	1	0	0.0	0.00	1.0e+00	CTTNBP2
Pack years adult smoking proportion	4.48	2	0	0.0	0.00	1.0e+00	CELF4 RP1-59D14.1
Impedance of leg (right)	1.32	3	1	2.2	0.00	1.0e+00	BNIPL RP1-59D14.1 SLC30A9
Leg fat-free mass (left)	0.87	2	0	0.0	0.00	1.0e+00	BNIPL HYI
Trunk fat percentage	2.37	5	1	2.2	-0.98	4.0e-03	BNIPL FOXP1 RP1-59D14.1 SLC30A9 ZDHHC5
Hand grip strength (right)	1.13	1	0	0.0	0.00	1.0e+00	FOXP1
Townsend deprivation index at recruitment	3.67	2	0	0.0	0.00	1.0e+00	CTTNBP2 ZDHHC5
Current tobacco smoking	4.81	2	0	0.0	0.00	1.0e+00	CELF4 CTTNBP2
Fed-up feelings	6.38	3	2	4.4	-0.99	7.6e-03	CELF4 CTTNBP2 ZDHHC5
Frequency of unenthusiasm / disinterest in last 2 weeks	5.51	2	0	0.0	0.00	1.0e+00	CTTNBP2 ZDHHC5
Relative age voice broke	1.61	1	0	0.0	0.00	1.0e+00	BNIPL
Taking other prescription medications	1.92	1	0	0.0	0.00	1.0e+00	ZBTB37
Age when periods started (menarche)	2.47	2	1	2.2	0.00	1.0e+00	BNIPL HYI
High blood pressure	1.48	2	0	0.0	0.00	1.0e+00	BNIPL HYI
Hayfever, allergic rhinitis or eczema	1.28	1	0	0.0	0.00	1.0e+00	SLC30A9
Stomach or abdominal pain in last month	1.34	1	0	0.0	0.00	1.0e+00	FOXP1
Supplements: Glucosamine	2.80	1	0	0.0	0.00	1.0e+00	SLC30A9
Sitting height	1.21	2	2	4.4	0.00	1.0e+00	HYI ZDHHC5
High blood pressure (mother)	2.29	1	0	0.0	0.00	1.0e+00	HYI
Body mass index (BMI)	1.53	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Impedance of leg (left)	1.36	3	1	2.2	0.00	1.0e+00	BNIPL RP1-59D14.1 SLC30A9
Leg predicted mass (left)	0.85	1	0	0.0	0.00	1.0e+00	BNIPL
Trunk fat mass	1.84	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Waist circumference	1.31	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Past tobacco smoking	2.73	2	0	0.0	0.00	1.0e+00	CTTNBP2 ZBTB37
Frequency of tenseness / restlessness in last 2 weeks	2.85	1	0	0.0	0.00	1.0e+00	ZBTB37
Forced vital capacity (FVC)	1.82	1	1	2.2	0.00	1.0e+00	FOXP1
Ever unenthusiastic/disinterested for a whole week	3.24	1	0	0.0	0.00	1.0e+00	SLC30A9
Qualifications: None of the above	5.47	4	1	2.2	-0.40	6.0e-01	CELF4 FOXP1 HYI ZDHHC5
Financial difficulties in last 2 years	3.86	1	0	0.0	0.00	1.0e+00	CTTNBP2
Allergy	1.10	1	0	0.0	0.00	1.0e+00	SLC30A9
Diabetes (self-reported)	2.29	1	0	0.0	0.00	1.0e+00	CTTNBP2
Fluid intelligence score	3.44	3	1	2.2	0.00	1.0e+00	FOXP1 HYI ZDHHC5
Neuroticism score	6.97	6	2	4.4	-0.73	6.1e-02	CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Weight	1.17	3	1	2.2	0.00	1.0e+00	BNIPL FOXP1 HYI
Impedance of arm (right)	1.23	2	0	0.0	0.00	1.0e+00	BNIPL ZDHHC5
Arm fat percentage (right)	2.16	3	2	4.4	0.00	1.0e+00	BNIPL FOXP1 ZDHHC5
Trunk fat-free mass	1.11	3	0	0.0	0.00	1.0e+00	BNIPL ZBTB37 ZDHHC5
Hip circumference	1.14	1	0	0.0	0.00	1.0e+00	BNIPL
Alcohol intake versus 10 years previously	2.76	1	0	0.0	0.00	1.0e+00	FOXP1
Worrier / anxious feelings	3.22	1	1	2.2	0.00	1.0e+00	ZDHHC5
Frequency of tiredness / lethargy in last 2 weeks	6.38	5	2	4.4	-0.68	2.0e-01	CTNND1 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Forced expiratory volume in 1-second (FEV1)	2.45	3	1	2.2	0.00	1.0e+00	CTTNBP2 FOXP1 ZDHHC5
Qualifications: A levels/AS levels or equivalent	4.21	5	0	0.0	0.99	8.5e-04	CELF4 CTTNBP2 FOXP1 HYI SLC30A9
Mouth/teeth dental problems: Dentures	1.83	1	0	0.0	0.00	1.0e+00	HYI
Asthma	1.53	1	0	0.0	0.00	1.0e+00	ZBTB37
Forced expiratory volume in 1-second (FEV1), Best measure	2.05	2	0	0.0	0.00	1.0e+00	FOXP1 ZDHHC5
Impedance of arm (left)	1.23	3	0	0.0	0.00	1.0e+00	BNIPL SLC30A9 ZDHHC5
Arm fat mass (right)	1.72	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Trunk predicted mass	1.09	3	0	0.0	0.00	1.0e+00	BNIPL ZBTB37 ZDHHC5
Standing height	0.59	2	0	0.0	0.00	1.0e+00	HYI ZDHHC5
Tense / 'highly strung'	2.81	2	0	0.0	0.00	1.0e+00	ZBTB37 ZDHHC5
Seen doctor (GP) for nerves, anxiety, tension or depression	5.01	3	0	0.0	-0.99	5.3e-03	CELF4 CTTNBP2 ZDHHC5
Peak expiratory flow (PEF)	2.31	2	0	0.0	0.00	1.0e+00	CTTNBP2 ZDHHC5
Qualifications: O levels/GCSEs or equivalent	2.74	1	0	0.0	0.00	1.0e+00	FOXP1
Medication: Paracetamol	2.52	1	0	0.0	0.00	1.0e+00	ZBTB37
Headache pain in last month	2.82	3	0	0.0	0.00	1.0e+00	FOXP1 ZBTB37 ZDHHC5
Forced vital capacity (FVC), Best measure	1.48	1	1	2.2	0.00	1.0e+00	FOXP1
Body fat percentage	2.53	4	1	2.2	-0.98	1.9e-02	BNIPL FOXP1 RP1-59D14.1 ZDHHC5
Leg fat percentage (right)	2.55	3	1	2.2	0.00	1.0e+00	BNIPL FOXP1 RP1-59D14.1
Arm fat-free mass (right)	1.10	2	1	2.2	0.00	1.0e+00	BNIPL ZDHHC5
Exposure to tobacco smoke outside home	3.69	1	1	2.2	0.00	1.0e+00	CTTNBP2
Comparative body size at age 10	1.55	1	0	0.0	0.00	1.0e+00	SLC30A9
Worry too long after embarrassment	6.32	3	2	4.4	0.00	1.0e+00	CTTNBP2 RP1-59D14.1 ZDHHC5
Seen a psychiatrist for nerves, anxiety, tension or depression	3.02	1	0	0.0	0.00	1.0e+00	CTTNBP2
Wheeze or whistling in the chest in last year	2.54	2	0	0.0	0.00	1.0e+00	CELF4 ZBTB37
Age at first live birth	2.65	1	0	0.0	0.00	1.0e+00	CELF4
Qualifications: College or University degree	6.03	8	3	6.7	0.98	2.1e-05	BNIPL CELF4 CTTNBP2 FOXP1 HYI RP1-59D14.1 ZBTB37 ZDHHC5
Medication for pain relief, constipation, heartburn	2.41	1	0	0.0	0.00	1.0e+00	ZBTB37
Mean time to correctly identify matches	1.59	1	0	0.0	0.00	1.0e+00	CELF4
Whole body fat mass	1.86	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Leg fat mass (right)	1.96	3	1	2.2	0.00	1.0e+00	BNIPL FOXP1 RP1-59D14.1
Arm predicted mass (right)	1.03	1	1	2.2	0.00	1.0e+00	BNIPL
Pulse rate, automated reading	2.86	4	1	2.2	-0.53	4.7e-01	HYI RP1-59D14.1 ZBTB37 ZDHHC5
Alcohol intake frequency.	3.97	3	1	2.2	0.00	1.0e+00	CTNND1 FOXP1 ZDHHC5
Comparative height size at age 10	0.95	1	1	2.2	0.00	1.0e+00	HYI
Overall health rating	4.97	4	2	4.4	-0.99	1.3e-02	FOXP1 RP1-59D14.1 ZBTB37 ZDHHC5
Illness, injury, bereavement, stress in last 2 years	3.02	1	0	0.0	0.00	1.0e+00	CTTNBP2
Hypertension (Self-reported)	1.28	2	0	0.0	0.00	1.0e+00	BNIPL HYI
Whole body fat-free mass	0.99	2	0	0.0	0.00	1.0e+00	BNIPL ZBTB37
Leg fat-free mass (right)	0.81	1	0	0.0	0.00	1.0e+00	BNIPL
Arm fat percentage (left)	2.17	3	2	4.4	0.00	1.0e+00	BNIPL FOXP1 ZDHHC5
Average weekly red wine intake	10.60	5	3	6.7	0.97	7.8e-03	CTNND1 FOXP1 RP11-385F5.4 RP1-59D14.1 ZDHHC5
Mood swings	4.24	2	0	0.0	0.00	1.0e+00	CELF4 CTTNBP2
Loneliness, isolation	3.24	1	0	0.0	0.00	1.0e+00	ZDHHC5
Long-standing illness, disability or infirmity	2.50	1	0	0.0	0.00	1.0e+00	FOXP1
Qualifications: nursing, teaching	3.55	1	0	0.0	0.00	1.0e+00	ZDHHC5
Mineral and other dietary supplements	2.94	1	0	0.0	0.00	1.0e+00	SLC30A9
Asthma (self-reported)	1.44	1	0	0.0	0.00	1.0e+00	ZBTB37
Smoking status: Current	4.26	2	0	0.0	0.00	1.0e+00	CELF4 CTTNBP2
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.91	1	0	0.0	0.00	1.0e+00	FOXP1
Whole body water mass	0.98	2	0	0.0	0.00	1.0e+00	BNIPL ZBTB37
Leg predicted mass (right)	0.84	1	0	0.0	0.00	1.0e+00	BNIPL
Arm fat mass (left)	1.78	2	1	2.2	0.00	1.0e+00	BNIPL FOXP1
Miserableness	4.52	3	0	0.0	0.00	1.0e+00	CELF4 CTTNBP2 ZBTB37
Guilty feelings	4.77	2	0	0.0	0.00	1.0e+00	CTTNBP2 ZDHHC5
Mother's age at death	2.06	1	0	0.0	0.00	1.0e+00	CTNND1
Pain type(s) experienced in last month: Hip pain	1.63	1	0	0.0	0.00	1.0e+00	FOXP1
Supplements: Fish oil (including cod liver oil)	2.14	1	0	0.0	0.00	1.0e+00	SLC30A9
Medication: Paracetamol	2.61	1	0	0.0	0.00	1.0e+00	ZBTB37
Ever smoked	3.96	1	1	2.2	0.00	1.0e+00	CTTNBP2
Basal metabolic rate	0.93	2	1	2.2	0.00	1.0e+00	BNIPL ZBTB37
Leg fat percentage (left)	2.45	3	2	4.4	0.00	1.0e+00	BNIPL FOXP1 RP1-59D14.1
Arm fat-free mass (left)	1.10	2	1	2.2	0.00	1.0e+00	BNIPL ZBTB37
Average weekly beer plus cider intake	5.12	2	0	0.0	0.00	1.0e+00	CELF4 CTTNBP2
Irritability	3.21	1	0	0.0	0.00	1.0e+00	CELF4
Fractured/broken bones in last 5 years	2.19	1	0	0.0	0.00	1.0e+00	CTTNBP2
Diastolic blood pressure, automated reading	1.14	1	0	0.0	0.00	1.0e+00	HYI
Unable to work because of sickness or disability	3.77	1	0	0.0	0.00	1.0e+00	ZDHHC5
Commuting to job workplace: Cycle	4.00	2	0	0.0	0.00	1.0e+00	FOXP1 RP1-59D14.1
Vascular/heart problems diagnosed by doctor	1.52	2	0	0.0	0.00	1.0e+00	BNIPL HYI
Pain experienced in last month	3.14	2	0	0.0	0.00	1.0e+00	FOXP1 ZBTB37
Pack years of smoking	4.31	2	0	0.0	0.00	1.0e+00	CELF4 RP1-59D14.1
Impedance of whole body	1.33	3	0	0.0	0.00	1.0e+00	BNIPL RP1-59D14.1 SLC30A9
Leg fat mass (left)	1.92	3	1	2.2	0.00	1.0e+00	BNIPL FOXP1 RP1-59D14.1
Arm predicted mass (left)	1.13	2	1	2.2	0.00	1.0e+00	BNIPL ZBTB37

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	2	0.057	1.6
GTEx	Adipose Visceral Omentum	2	0.098	1.7
GTEx	Adrenal Gland	1	0.069	1.7
GTEx	Artery Aorta	0	0.000	1.6
GTEx	Artery Coronary	0	0.000	1.6
GTEx	Artery Tibial	1	0.027	1.7
GTEx	Brain Caudate basal ganglia	2	0.217	1.7
GTEx	Brain Cerebellar Hemisphere	1	0.067	1.7
GTEx	Brain Cerebellum	0	0.000	1.6
GTEx	Brain Cortex	0	0.000	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Hippocampus	0	0.000	1.4
GTEx	Brain Hypothalamus	0	0.000	1.6
GTEx	Brain Nucleus accumbens basal ganglia	1	0.116	1.6
GTEx	Brain Putamen basal ganglia	0	0.000	1.7
GTEx	Breast Mammary Tissue	2	0.101	1.7
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.6
GTEx	Breast Mammary Tissue (Female)	1	0.061	1.6
GTEx	Cells EBV-transformed lymphocytes	2	0.141	1.6
GTEx	Cells Transformed fibroblasts	4	0.095	1.6
GTEx	Colon Sigmoid	0	0.000	1.7
GTEx	Colon Transverse	2	0.097	1.6
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.6
GTEx	Esophagus Mucosa	1	0.030	1.7
GTEx	Esophagus Muscularis	1	0.031	1.7
GTEx	Heart Atrial Appendage	0	0.000	1.7
GTEx	Heart Left Ventricle	2	0.131	1.7
GTEx	Liver	0	0.000	1.5
GTEx	Lung	5	0.174	1.7
GTEx	Muscle Skeletal	0	0.000	1.7
GTEx	Nerve Tibial	1	0.023	1.6
GTEx	Ovary	0	0.000	1.6
GTEx	Pancreas	1	0.061	1.7
GTEx	Pituitary	0	0.000	1.5
GTEx	Prostate	0	0.000	1.5
GTEx	Skin Not Sun Exposed Suprapubic	3	0.122	1.7
GTEx	Skin Sun Exposed Lower leg	4	0.110	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.6
GTEx	Spleen	0	0.000	1.6
GTEx	Stomach	2	0.138	1.7
GTEx	Testis	2	0.063	1.6
GTEx	Thyroid	2	0.050	1.7
GTEx	Uterus	0	0.000	1.5
GTEx	Vagina	0	0.000	1.9
GTEx	Whole Blood	0	0.000	1.6
METSIM	Adipose	2	0.043	1.5
NTR	Blood	2	0.083	1.6
ROSMAP	Brain Pre-frontal Cortex	2	0.046	1.7
YFS	Blood	2	0.043	1.6
CommonMind	Brain Pre-frontal Cortex	4	0.074	1.7
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	3	0.181	1.7
The Cancer Genome Atlas	Breast Invasive Carcinoma	2	0.045	1.6
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Esophageal Carcinoma	1	0.146	1.7
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.5
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	1	0.037	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	1	0.049	1.6
The Cancer Genome Atlas	Brain Lower Grade Glioma	4	0.093	1.7
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	1	0.034	1.7
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	1	0.040	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	1	0.022	1.6
The Cancer Genome Atlas	Rectum Adenocarcinoma	1	0.145	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.094	1.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	1	0.078	1.6
The Cancer Genome Atlas	Thyroid Carcinoma	2	0.039	1.6
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.5